Quantoom Biosciences

Booth 1664
Quantoom Biosciences, is reinventing mRNA production by developing an RNA Platform that encompasses DNA and RNA manufacturing and formulation, along with critical reagent supply, from sequence to large scale production. Quantoom’s approach to the production of mRNA vaccines involves redesigning the entire manufacturing process from start to finish. By doing this, Quantoom Biosciences can produce mRNA vaccines faster, more efficiently, and at a lower cost than traditional methods.